PMID- 33081139 OWN - NLM STAT- MEDLINE DCOM- 20210419 LR - 20210419 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 12 IP - 10 DP - 2020 Oct 16 TI - Inconsistencies in the Nutrition Management of Glutaric Aciduria Type 1: An International Survey. LID - 10.3390/nu12103162 [doi] LID - 3162 AB - Glutaric aciduria type 1 (GA-1) is a cerebral organic aciduria characterized by striatal injury and progressive movement disorder. Nutrition management shifted from a general restriction of intact protein to targeted restriction of lysine and tryptophan. Recent guidelines advocate for a low-lysine diet using lysine-free, tryptophan-reduced medical foods. GA-1 guideline recommendations for dietary management of patients over the age of six are unclear, ranging from avoiding excessive intake of intact protein to counting milligrams of lysine intake. A 22-question survey on the nutrition management of GA-1 was developed with the goal of understanding approaches to diet management for patients identified by newborn screening under age six years compared to management after diet liberalization, as well as to gain insight into how clinicians define diet liberalization. Seventy-six responses (25% of possible responses) to the survey were received. Nutrition management with GA-1 is divergent among surveyed clinicians. There was congruency among survey responses to the guidelines, but there is still uncertainty about how to counsel patients on diet optimization and when diet liberalization should occur. Ongoing clinical research and better understanding of the natural history of this disease will help establish stronger recommendations from which clinicians can best counsel families. FAU - Bernstein, Laurie AU - Bernstein L AD - Department of Pediatrics, Section of Medical Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. FAU - Coughlin, Curtis R AU - Coughlin CR AD - Department of Pediatrics, Section of Medical Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. FAU - Drumm, Morgan AU - Drumm M AD - Department of Pediatrics, Section of Medical Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. FAU - Yannicelli, Steven AU - Yannicelli S AUID- ORCID: 0000-0002-3277-6466 AD - Nutricia North America, Rockville, MD 20850, USA. FAU - Rohr, Fran AU - Rohr F AD - Met Ed Co, Boulder, CO 80302, USA. LA - eng PT - Journal Article DEP - 20201016 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 RN - 0 (Dietary Proteins) RN - 8DUH1N11BX (Tryptophan) RN - EC 1.3.8.6 (Glutaryl-CoA Dehydrogenase) RN - K3Z4F929H6 (Lysine) RN - Glutaric Acidemia I SB - IM MH - Amino Acid Metabolism, Inborn Errors/*diet therapy MH - Brain Diseases, Metabolic/*diet therapy MH - Child MH - Child Nutritional Physiological Phenomena/*physiology MH - Child, Preschool MH - Diet Therapy/*methods MH - Dietary Proteins/*administration & dosage MH - Female MH - Glutaryl-CoA Dehydrogenase/*deficiency MH - Humans MH - Infant MH - Infant Nutritional Physiological Phenomena/*physiology MH - Infant, Newborn MH - Lysine/*adverse effects MH - Male MH - Practice Guidelines as Topic MH - Recommended Dietary Allowances MH - Surveys and Questionnaires MH - Tryptophan/*adverse effects PMC - PMC7602866 OTO - NOTNLM OT - diet OT - glutaric acidemia type 1 OT - glutaric aciduria type 1 OT - lysine-restricted OT - nutrition OT - protein COIS- The authors declare no conflict of interest. EDAT- 2020/10/22 06:00 MHDA- 2021/04/20 06:00 PMCR- 2020/10/01 CRDT- 2020/10/21 01:02 PHST- 2020/09/16 00:00 [received] PHST- 2020/10/09 00:00 [revised] PHST- 2020/10/12 00:00 [accepted] PHST- 2020/10/21 01:02 [entrez] PHST- 2020/10/22 06:00 [pubmed] PHST- 2021/04/20 06:00 [medline] PHST- 2020/10/01 00:00 [pmc-release] AID - nu12103162 [pii] AID - nutrients-12-03162 [pii] AID - 10.3390/nu12103162 [doi] PST - epublish SO - Nutrients. 2020 Oct 16;12(10):3162. doi: 10.3390/nu12103162.